1Kato H, Torigoe T. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma[J]. Cancer, 1977, 40 (4) : 1621.
2Crombach G, Scharl A, Vierbuchen M et al. Detection of squamous cell carcinoma antigen in normal squamous epithelia and in squamous cell carcinoma of the ulerine cervix [J]. Cancer, 1989, 63 (7) : 1337.
3Maiman M, Feuer G, Fruchter RG et al. Value of squamous cell carcinoma antigen levels in invaslve cervical carcinoma [J]. Gynecol Oncol, 1989, 34 (3): 312.
4Duk JM, Groenier KH, De Bruijn HW et al. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early -stage cervical carcinoma [J].J Clin Oncol, 1996, 14 (1) : 111.
7Bolger BS, Dabbas M, Lopes A et al. Prognostic value of preoperative squamous cell carcinoma antigen level in patients surgically treated for cervical carcinoma[J]. Gynecol Oncol, 1997, 65 (2): 309.
8de Brui jn HW, Duk TM, Van der Zee AG et al. The clinical value of squamous cell carcinoma antigen in cancer of the uterine cervix [J].Tumour Biol, 1998, 19 (6): 505.
6[11] Abe H, Okuno N, Takeda O, et al. Anakysis of heterogeneity of squamous cellcarcinoma antigen by two dimensional electrophoresis [J]. Electrophoresis, 1994, 15:988-991.
7[12] Bolli J A N, Docering D L, Bosscher J R, et al. Squamous cell carcinoma antigen: Clinical utility in squamous cell carcinoma of cervix [J]. Gynecol Oncol, 1994,55:169-173.
8[13] De Cos S J, Masa F, de la Cruz J L, et al. Squamous cell carcinoma antigen (SCC Ag) in the diagnosis and prognosis of lung cancer [J]. Chest, 1994,105:773-776.
9[14] Lachowicz M A, Hassmann P E, Rzewnicki, et al. Squamous cell carcinoma antigen in patients with cancer of the larynx [J]. Clin Otolaryngol, 1999, 24:270-3
10[1] Silverman G A, Bartuski A J, Cataltepe S, et al. SCC Ag-1and SCC Ag-2 are proteinase inhibitors that map to the serpin cluster at 18q21.3 [J]. Tumor Biol, 1998, 19:450-487.
5Molina R, Filella X, Auge JM, et al. Tumor markers (CEA, CA125, CyFRA21-1, SCC and NSE) in patients with non-small cell lung cancer as aid in histoligical diangnosis and prognosis:comparison with the main clinical and pathological prognostic factors [J]. Tumor Biol, 2003,24 (4) : 209-218.
6Ferdeghini M, Gadducci A, Annicchiarico C, et al. Serum CyFRA21-1 assay in squamous cell carcinoma of the cervix [J]. Anticancer Res, 1993,13(5C) : 1841-1844.
7Pras E, Willemse PH, Canrinus AA, et al. Serum squamous cell carcinoma antigen and CyFRA21-1 in cervical cancer treatment [J]. Int J Radiat Oncnl Biol Phys,2002, 52(1) :23-32.
8Homma S, Harada M, Yano H et al. Identification of squa- mous cell carcinoma antigen derived peptides having the capac- ity of inducing cancer reactive CTLs in HLA - A24 + cancer patients [J] . Int J Oncol, 2006, 29 (3): 577.
9Katagiri C, Nakanishi J, Kadoya K et al. Serpin squamous cell carcinoma antigen inhibits UV - induced apoptosis via suppression of c - JUNNH2 - terminal kinase [J]. J Cell Bi- ol, 2006, 172 (7): 983.
10Gadducci A, Tana R, Fanucchi A et al. Biochemical prog- nostic factors and risk of relapses in patients with cervical canc- er [J]. Gyneeol Oncol, 2007, 107 (1 Suppl 1) : $23.
